The document discusses the results of a study on the effects of a new drug on memory and cognitive function in older adults. The double-blind study involved giving either a placebo or the experimental drug to 100 volunteers aged 65-80 over 6 months. Testing showed those receiving the drug performed significantly better on memory recall tasks and had improved scores on standard cognitive assessments compared to the placebo group.
